Adicet Bio, Inc.
ACET
$0.8345
$0.00660.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.97M | 7.07M | 7.47M | 6.90M | 6.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.39M | 29.89M | 30.74M | 33.15M | 32.85M |
| Operating Income | -32.39M | -29.89M | -30.74M | -33.15M | -32.85M |
| Income Before Tax | -31.22M | -28.21M | -28.73M | -30.48M | -29.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.22M | -28.21M | -28.73M | -30.48M | -29.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.22M | -28.21M | -28.73M | -30.48M | -29.90M |
| EBIT | -32.39M | -29.89M | -30.74M | -33.15M | -32.85M |
| EBITDA | -30.74M | -28.21M | -29.12M | -31.56M | -31.25M |
| EPS Basic | -0.34 | -0.31 | -0.32 | -0.34 | -0.33 |
| Normalized Basic EPS | -0.21 | -0.19 | -0.20 | -0.21 | -0.21 |
| EPS Diluted | -0.34 | -0.31 | -0.32 | -0.34 | -0.33 |
| Normalized Diluted EPS | -0.21 | -0.19 | -0.20 | -0.21 | -0.21 |
| Average Basic Shares Outstanding | 91.09M | 91.07M | 90.85M | 90.85M | 90.63M |
| Average Diluted Shares Outstanding | 91.09M | 91.07M | 90.85M | 90.85M | 90.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |